Literature DB >> 17043886

Procalcitonin serum levels in children undergoing chronic haemodialysis.

Fleur Lorton1, Frédérique Veinberg, Dominique Ielsch, Georges Deschênes, Albert Bensman, Tim Ulinski.   

Abstract

Infections account for considerable morbidity and mortality in patients requiring haemodialysis (HD). Procalcitonin (PCT)-a low molecular weight protein of 13 kDa-helps one to distinguish viral from bacterial infections and to evaluate the severity of bacterial infections. We investigated (1) PCT baseline levels in eight children undergoing chronic HD with high-flux membranes and (2) changes in the serum levels of PCT, C-reactive protein (CRP) and beta-2-microglobulin (beta2-MG)-a peptide with biochemical characteristics similar to those of PCT-before and after haemodialysis sessions. Blood sampling was performed three times in the mid-week session. Serum PCT of the seven uninfected children before HD sessions was increased (0.75+/-0.07 ng/ml), whereas CRP levels were normal. PCT after dialysis decreased significantly by 40% (P<0.0001) compared with initial values, whereas CRP levels before and after HD were not different. beta2-MG decreased by 70%, probably due to different biochemical properties of both proteins. PCT serum levels 15 min and 60 min after the HD session remained unchanged in comparison with those at the end of the HD session, suggesting accumulation of PCT between HD sessions rather than HD-induced production to be responsible for the increased baseline PCT serum levels. We concluded that CRP serum levels were not affected by HD in our group. Moderately elevated baseline PCT serum levels that are presumably due to reduced renal clearance and uraemia and dialysis-ability of PCT should be taken into consideration. However, increase of serum PCT in patients with severe bacterial infections is generally massive (10-fold to 1,000-fold), suggesting a low risk for false negative results in such cases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17043886     DOI: 10.1007/s00467-006-0304-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  29 in total

1.  Increase of C-reactive protein serum values following haemodialysis.

Authors:  M Haubitz; M Schulze; K M Koch
Journal:  Nephrol Dial Transplant       Date:  1990       Impact factor: 5.992

2.  Flow cytometric analysis of procalcitonin expression in human monocytes and granulocytes.

Authors:  Attila Balog; Imre Ocsovszki; Yvette Mándi
Journal:  Immunol Lett       Date:  2002-12-03       Impact factor: 3.685

3.  Procalcitonin as a marker of micro-inflammation in hemodialysis.

Authors:  Giovanni Conti; Alessandro Amore; Monica Chiesa; Domenico Mancuso; Paola Cirina; Giulio Mengozzi; Antonio Santoro; Rosanna Coppo
Journal:  J Nephrol       Date:  2005 May-Jun       Impact factor: 3.902

4.  Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy.

Authors:  M Haubitz; R Brunkhorst; E Wrenger; P Froese; M Schulze; K M Koch
Journal:  Perit Dial Int       Date:  1996 Mar-Apr       Impact factor: 1.756

Review 5.  Procalcitonin as an early marker of infection in neonates and children.

Authors:  A M C van Rossum; R W Wulkan; A M Oudesluys-Murphy
Journal:  Lancet Infect Dis       Date:  2004-10       Impact factor: 25.071

6.  C-reactive protein as an outcome predictor for maintenance hemodialysis patients.

Authors:  W F Owen; E G Lowrie
Journal:  Kidney Int       Date:  1998-08       Impact factor: 10.612

7.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

8.  Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis.

Authors:  E S Nylen; K T Whang; R H Snider; P M Steinwald; J C White; K L Becker
Journal:  Crit Care Med       Date:  1998-06       Impact factor: 7.598

9.  Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit.

Authors:  Canan BalcI; Hülya Sungurtekin; Ercan Gürses; Ugur Sungurtekin; Bünyamin Kaptanoglu
Journal:  Crit Care       Date:  2002-10-30       Impact factor: 9.097

Review 10.  Procalcitonin--a new indicator of the systemic response to severe infections.

Authors:  W Karzai; M Oberhoffer; A Meier-Hellmann; K Reinhart
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

View more
  6 in total

1.  Predictive value of procalcitonin for diagnosis of infections in patients with chronic kidney disease: a comparison with traditional inflammatory markers C-reactive protein, white blood cell count, and neutrophil percentage.

Authors:  Yanbei Sun; Lijuan Jiang; Xiaonan Shao
Journal:  Int Urol Nephrol       Date:  2017-09-27       Impact factor: 2.370

2.  Plasma calprotectin in chronically dialyzed end-stage renal disease patients.

Authors:  Karin Malícková; Helena Brodská; Jana Lachmanová; Sylvie Dusilová Sulková; Ivana Janatková; Helena Marecková; Vladimír Tesar; Tomás Zima
Journal:  Inflamm Res       Date:  2009-10-25       Impact factor: 4.575

3.  Procalcitonin serum levels in stage 5 chronic kidney disease children on hemodialysis.

Authors:  Antoine Mouche; Cyrielle Parmentier; Claire Herbez Rea; Thérèsa Kwon; Olivia Boyer; Jean Daniel Delbet; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2021-03-17       Impact factor: 3.714

4.  Diagnostic value of procalcitonin for bacterial infections in patients undergoing hemodialysis: a systematic review and meta-analysis.

Authors:  Mei Tao; Danna Zheng; Xudong Liang; Qiang He; Wei Zhang
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

5.  Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study.

Authors:  Helena Brodska; Tomas Drabek; Karin Malickova; Antonin Kazda; Antonin Vitek; Tomas Zima; Marketa Markova
Journal:  Crit Care       Date:  2009-03-16       Impact factor: 9.097

6.  Usefulness of serum procalcitonin as a diagnostic biomarker of infection in children with chronic kidney disease.

Authors:  Fatina I Fadel; Manal F Elshamaa; Eman A Elghoroury; Ahmed M Badr; Solaf Kamel; Marwa M El-Sonbaty; Mona Raafat; Hebatallh Farouk
Journal:  Arch Med Sci Atheroscler Dis       Date:  2016-05-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.